United States · FDA National Drug Code directory
Losartan Potassium and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16714-226_d3aeeeca-2c3a-4006-89f7-e3836aa8399b
- Product NDC
- 16714-226
- Form
- TABLET, FILM COATED
- Composition / generic term
- Losartan Potassium and Hydrochlorothiazide
- Labeler
- NorthStar Rx LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240904
- Source listing expiry
- 20261231
Source-listed ingredients
- LOSARTAN POTASSIUM — 50 mg/1
- HYDROCHLOROTHIAZIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (16714-226-01) · 16714-226-01
- 90 TABLET, FILM COATED in 1 BOTTLE (16714-226-02) · 16714-226-02
- 1000 TABLET, FILM COATED in 1 BOTTLE (16714-226-04) · 16714-226-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →